Colon Cancer News
-
Results from Given Imaging Ltd.’s latest clinical study of a pill-sized camera used to identify colon cancer probably will help the Israeli manufacturer secure U.S. regulatory approval this year, Chief Executive Officer Homi Shamir said.
-
Walter J. O’Brien III, head of equity sales and trading at BB&T Corp. and a mentor to finance-minded graduates of his alma mater, the University of Richmond in Virginia, has died. He was 46.
-
Should patients undergoing broad DNA testing for a specific ailment be told of unexpected findings that signal risk of cancer or other serious diseases, even if they don’t request the information?
-
Bristol-Myers Squibb Co. sued Roche Holding AG’s Genentech unit seeking a court order that it doesn’t infringe patents used to make treatments for cancer and autoimmune diseases.
-
Bristol-Myers Squibb Co. sued Roche Holding AG’s Genentech unit seeking a ruling it doesn’t infringe patents used to make treatments for cancer and autoimmune diseases.
-
A novel test from Genomic Health Inc. helps predict whether prostate cancer is aggressive or slow- growing, giving patients and doctors more information to shape treatment for the most common tumor found in men, a study found.
-
An analysis of the most common uterine cancer suggests the disease should be reclassified into four categories that may help lead to more targeted treatments.
-
Genetic testing is becoming cheaper and more widespread, promising to usher in a revolution in cancer treatment. Yet, long-standing DNA tests are often overlooked for reasons including doctors’ ignorance and financial incentives discouraging companies from marketing them.
-
The first man on the moon, the first U.S. woman in space and the first black Federal Reserve member were among the notable deaths in 2012.
-
Regular use of aspirin may keep colon cancer from killing patients whose tumors contain a specific gene defect, according to a study that shows how modern gene science can guide use of old drugs.
|
|
Most Popular on Bloomberg
|
| |